Company Profile

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE5381.5518.45 (+0.34 % )
PREV CLOSE (Rs.) 5363.10
OPEN PRICE (Rs.) 5399.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 912
TODAY'S LOW / HIGH (Rs.)5371.00 5434.00
52 WK LOW / HIGH (Rs.)4803.5 7499.95
NSE5386.70 25.4 (+0.47 % )
PREV CLOSE(Rs.) 5361.30
OPEN PRICE (Rs.) 5400.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 5386.70 (20 )
VOLUME 14917
TODAY'S LOW / HIGH(Rs.) 5371.20 5418.95
52 WK LOW / HIGH (Rs.)4800 7500

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 2.42
TTM EPS (Rs.) 106.51
P/E Ratio 50.53
Book Value (Rs.) 423.94
Face Value (Rs.) 10
MCap (Rs. in Mn) 89330.40
Price/Earning (TTM) 43.19
Price/Sales (TTM) 8.86
Price/Book (MRQ) 12.69
PAT Margin (%) 18.74
ROCE (%) 29.01
Incorporation Year : 1967

Management Info :

Suresh N Talwar - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Godrej One, 8th Floor,Pirojshanagar,Eastern Express Highway, Vikhroli (East),
Mumbai,
Maharashtra-400079

Phone : 022 6866 9000

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
18Sep09-18-2021$Procter & Gamble Health informs about 54th AGM Procter & Gamble Health info

Procter & Gamble Health has informed that the 54th Annual General Meeting of the Company is to be held on Thursday, November 11, 2021 through Video Conferencing/ Other Audio-visual means, in compliance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India due to the current COVID-19 pandemic. The Register of Members and Share Transfer books shall remain closed from Friday, November 05, 2021, to Thursday, November 11, 2021 for the purposes of Annual General Meeting and payment of dividend for the year ended June 30, 2021, if approved by members at the 54th Annual General Meeting. The notice convening the 54th Annual General Meeting of the Company will be provided in due course of time.

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that the 54th Annual G..
27Aug08-27-2021$Procter & Gamble Health informs about change in directorate Procter & Gamble Health info
Procter & Gamble Health has informed that the Board of Directors of the Company, at its meeting held today, have appointed Elizabeth Desmond as an Additional (Non-Executive) Director of the Company with effect from allotment of Director Identification Number by the Ministry of Corporate Affairs. Elizabeth Desmond will hold office as Additional Director up to the ensuing 54th Annual General Meeting. She does not hold any shares in the Company and is not related to any of the Directors of the Company.

The above information is a part of company’s filings submitted to BSE

Procter & Gamble Health has informed that the Board of Dire..
27Aug08-27-2021$Procter & Gamble Health informs about revised intimation regarding appointment of CS Procter & Gamble Health info

With reference to the stock exchange disclosure dated August 26, 2021, on the Appointment of CS of the Company, there was an inadvertent error in the brief profile of Zeal Shah. The revised intimation shall read as follows. In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Procter & Gamble Health has informed that, the Board of directors at their meeting held on August 26, 2021, have appointed Zeal Shah as the Company Secretary (CS) of the Company with effect from August 26, 2021. Brief Profile of Shah is attached.

The above information is a part of company’s filings submitted to BSE.

With reference to the stock exchange disclosure dated August 26..
27Aug08-27-2021$ Appointment of Company Secretary and Compliance Officer Appointment of Company Secr
In accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that, the Board of directors at their meeting held today have appointed Ms. Zeal Shah as the Company Secretary of the Company with immediate effect. Brief Profile of Ms. Shah is as below: Ms. Zeal Shah is a Commerce and a Law graduate, she is an Associate Member of the Institute of Company Secretaries of India (ACS 52286). Ms. Shah has a work experience of 4 years in the field of Corporate & Securities Laws. Presently, she is the Compliance Officer of the Company under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI (Prohibition of Insider Trading) Regulations, 2015. Kindly take the same on record and oblige.
In accordance with Regulation 30 of the SEBI (Listing Obligatio..
16Aug08-16-2021$Procter & Gamble Health informs about board meeting Procter & Gamble Health info

Procter & Gamble Health has informed that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, August 26, 2021, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2021 and to consider recommendation of dividend (if any).

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that a meeting of the..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit338.91768
Gross Profit 435.3 2332.8
Operating Profit 508.5999999999992641.2
Net Sales 2853.910087.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
JB Chem & Pharma (BSE)
 1836.10 (5.26%)
M.Cap ( in Cr)
14189.77
Alkem Laboratories (BSE)
 4001.85 (0.95%)
M.Cap ( in Cr)
47848.12
Kwality Pharma (BSE)
 688.70 (4.99%)
M.Cap ( in Cr)
714.61
Hester Biosciences (BSE)
 2518.75 (0.91%)
M.Cap ( in Cr)
2142.67
Chandra Bhagat Pharm (BSE)
 124.55 (14.27%)
M.Cap ( in Cr)
93.97
Shareholding Pattern More
MUTUAL FUNDS/UTI 6.6 %
PROMOTERS 51.82 %
FI/BANKS/INSURANCE 5.21 %
NON-INSTITUTION 29.93 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes